Skip to content
The Nexus
HEALTHMay 27 · 21:11 UTCTECHCRUNCHMarina Temkin

Triomics nabs $22M to bring oncology-specific AI to cancer centers

Triomics secured $22 million in a Series B funding round led by Battery Ventures to develop oncology-specific AI tools for cancer centers. The investment aims to advance AI-driven solutions tailored to oncology care.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
TriomicsorganizationBattery Venturesorganizationoncology-specific AItopiccancer centerstopicSeries B roundtopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting